These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 5264216

  • 1. Drug-resistant pulmonary tuberculosis in Norway. Preliminary report.
    Bjartveit K.
    Scand J Respir Dis Suppl; 1969; 69():21-2. PubMed ID: 5264216
    [No Abstract] [Full Text] [Related]

  • 2. The prognosis of pulmonary tuberculosis under modern treatment.
    Thomassen OK.
    Scand J Respir Dis Suppl; 1968; 63():29-32. PubMed ID: 5188461
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract] [Full Text] [Related]

  • 4. [Primary resistance to the major antitubercular drugs in pulmonary tuberculosis patients during 1961-1966].
    Jaroszewicz W, Buraczewska M, Pichulowa K, Pszonicka A, Zych D.
    Gruzlica; 1968 Oct; 37(1):17-21. PubMed ID: 5720034
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical value of the complex determination of the drug resistance of Mycobacterium tuberculosis].
    Gur'ian IE.
    Sov Med; 1973 Apr; 36(4):94-7. PubMed ID: 4203677
    [No Abstract] [Full Text] [Related]

  • 6. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)].
    Burghard G, Petitjean R, Schranz J, Scherrer B.
    Rev Tuberc Pneumol (Paris); 1970 Apr; 34(3):439-53. PubMed ID: 5515514
    [No Abstract] [Full Text] [Related]

  • 7. [Comparative study on an intermittent mode of pulmonary tuberculosis therapy using streptomycin and isoniazid].
    Burzibu JM, Durante C, Ceicu A, el Fassi el Fahri M, Bahsoun H.
    Maroc Med; 1974 May; 54(579):307-13. PubMed ID: 4444314
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Preliminary findings and considerations on primary resistance to SM, INI, and PAS in the Provincial Antitubercular Association of Naples].
    Romano S, Grella G.
    Rass Int Clin Ter; 1966 Dec 15; 46(23):1311-6. PubMed ID: 5997869
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Antibacterial therapy of pulmonary tuberculosis in the Bulgarian People's Republic and possibilities of its improvement].
    Dimitrov DA.
    Z Tuberk Erkr Thoraxorg; 1965 Jul 15; 123(4):342-3. PubMed ID: 5897865
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Results of routine treatment of pulmonary tuberculosis patients treated for the 1st time].
    Bernard E, Abadi O, Pretet S.
    Rev Tuberc Pneumol (Paris); 1969 Nov 15; 33(7):967-74. PubMed ID: 5402999
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Test-therapy to determine the activity of minor forms of pulmonary tuberculosis].
    Rastvortseva TN.
    Probl Tuberk; 1971 Nov 15; 49(6):31-4. PubMed ID: 5117826
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.